These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 24517245

  • 1. Combined heart-liver transplantation in the MELD era: do waitlisted patients require exception status?
    Schaffer JM, Chiu P, Singh SK, Oyer PE, Reitz BA, Mallidi HR.
    Am J Transplant; 2014 Mar; 14(3):647-59. PubMed ID: 24517245
    [Abstract] [Full Text] [Related]

  • 2. Heart and combined heart-kidney transplantation in patients with concomitant renal insufficiency and end-stage heart failure.
    Schaffer JM, Chiu P, Singh SK, Oyer PE, Reitz BA, Mallidi HR.
    Am J Transplant; 2014 Feb; 14(2):384-96. PubMed ID: 24279876
    [Abstract] [Full Text] [Related]

  • 3. Nonstandard Exception Requests Impact Outcomes for Pediatric Liver Transplant Candidates.
    Braun HJ, Perito ER, Dodge JL, Rhee S, Roberts JP.
    Am J Transplant; 2016 Nov; 16(11):3181-3191. PubMed ID: 27214757
    [Abstract] [Full Text] [Related]

  • 4. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE.
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [Abstract] [Full Text] [Related]

  • 5. Incidence and Risk Factors for Stroke After Combined Heart-Kidney and Heart-Liver Transplantation.
    Akbar AF, Rokui S, Zhou AL, Kilic A, King E, Cho SM.
    Clin Transplant; 2024 Jun; 38(6):e15369. PubMed ID: 39031709
    [Abstract] [Full Text] [Related]

  • 6. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.
    Atiemo K, Skaro A, Maddur H, Zhao L, Montag S, VanWagner L, Goel S, Kho A, Ho B, Kang R, Holl JL, Abecassis MM, Levitsky J, Ladner DP.
    Am J Transplant; 2017 Sep; 17(9):2410-2419. PubMed ID: 28226199
    [Abstract] [Full Text] [Related]

  • 7. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
    Ravaioli M, Lai Q, Sessa M, Ghinolfi D, Fallani G, Patrono D, Di Sandro S, Avolio A, Odaldi F, Bronzoni J, Tandoi F, De Carlis R, Pascale MM, Mennini G, Germinario G, Rossi M, Agnes S, De Carlis L, Cescon M, Romagnoli R, De Simone P.
    J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
    [Abstract] [Full Text] [Related]

  • 8. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK, DiNorcia J, Ji L, Groshen S, Levitsky J, Sung RS, Kim WR, Andreoni K, Mulligan D, Genyk YS.
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [Abstract] [Full Text] [Related]

  • 9. Excess waitlist mortality among candidates for multivisceral liver-intestine transplant in acuity circle allocation.
    Kwong AJ, Schnellinger E, Foutz J, Cafarella M, Nagai S, Biggins SW, Pomposelli J, Trotter J.
    Am J Transplant; 2024 Jun; 24(6):1080-1086. PubMed ID: 38408641
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The decreasing predictive power of MELD in an era of changing etiology of liver disease.
    Godfrey EL, Malik TH, Lai JC, Mindikoglu AL, Galván NTN, Cotton RT, O'Mahony CA, Goss JA, Rana A.
    Am J Transplant; 2019 Dec; 19(12):3299-3307. PubMed ID: 31394020
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M, Kornfield R, Vittinghoff E, Inadomi JM, Biggins SW.
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
    Lee J, Kim DG, Lee JY, Lee JG, Joo DJ, Kim SI, Kim MS.
    Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
    [Abstract] [Full Text] [Related]

  • 19. Comparison of combined heart‒liver vs heart-only transplantation in pediatric and young adult Fontan recipients.
    Sganga D, Hollander SA, Vaikunth S, Haeffele C, Bensen R, Navaratnam M, McDonald N, Profita E, Maeda K, Concepcion W, Bernstein D, Chen S.
    J Heart Lung Transplant; 2021 Apr; 40(4):298-306. PubMed ID: 33485775
    [Abstract] [Full Text] [Related]

  • 20. Outcomes After Declining a Steatotic Donor Liver for Liver Transplant Candidates in the United States.
    Jackson KR, Bowring MG, Holscher C, Haugen CE, Long JJ, Liyanage L, Massie AB, Ottmann S, Philosophe B, Cameron AM, Segev DL, Garonzik-Wang J.
    Transplantation; 2020 Aug; 104(8):1612-1618. PubMed ID: 32732838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.